Literature DB >> 34998633

Complications and survival after total pelvic exenteration.

Cathrine Kure Pleth Nielsen1, Mette Møller Sørensen2, Henrik Kidmose Christensen2, Jonas Amstrup Funder2.   

Abstract

BACKGROUND: Pelvic exenteration is a procedure with high morbidity despite careful patient selection. This study investigates potential associations between perioperative markers and major postoperative complications including survival.
METHODS: Retrospectively collected data for 195 consecutive patients who underwent total pelvic exenteration (January 2015-February 2020) at a single tertiary university hospital were analyzed.
RESULTS: The 30-day mortality was 0.5%, and the rate of major postoperative complications (≥3 Clavien-Dindo) was 34.5%. Low albumin level (p = 0.02) and blood transfusion (p = 0.02) were significantly correlated with a major postoperative complication in univariate analyses. This had no impact on survival. Positive margins (p = 0.003), liver metastasis (p = 0.001) were related to poor survival in multivariate analyses for colorectal patients. A Charlson Comorbidity Index >6 (p < 0.05) was associated with poor survival in all patients.
CONCLUSION: The occurrence of major postoperative complication does not negatively impact the overall survival. Pelvic exenteration is a potential life-prolonging operation when negative margins can be obtained, despite known risks for complications. Comorbidity is a predictor for inferior outcomes.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer; Postoperativ complications; Survival; Total pelvic exenteration

Mesh:

Year:  2022        PMID: 34998633     DOI: 10.1016/j.ejso.2021.12.472

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.037


  1 in total

1.  Using Bakri balloon as a visceral replacement for occupying pelvic cavity in pelvic exenteration, a case report.

Authors:  Soheila Aminimoghaddam; Nafisseh Hivehchi; Marjan Ghaemi; Arefeh Eshghinejad; Maryam Yazdizadeh
Journal:  Int J Surg Case Rep       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.